Professionally Psychedelics Podcast – Tim Schlidt, Palo Santo
For this episode, Tim Schlidt, Co-Founder and Partner at psychedelics VC firm, Palo Santo joined the pod in conversation.
The psychedelics industry has experienced growth at breakneck speed over the past two years, with swathes...
Ayahuasca, Trauma and Healing | Interview with Carlos Tanner, Ayahuasca Foundation
Carlos Tanner, Founder & Director at the Ayahuasca Foundation joined the GCI Content Hub in conversation.
Could you give our readers an overview of your background, and what led you to psychedelics?
As a child...
Leveraging IP in Psychedelics and Cannabis
Watch insights from our Leveraging IP for Business Growth in Cannabis & Psychedelics discussion at the GCI Virtual Summit (June 2021) with Ronan Levy, Field Trip Health; Dr. Jeffrey Becker, Bexson Biomedical; and Dr....
Professionally Psychedelics Podcast – Ben Lightburn, Filament Health
Tune into this episode of the podcast to hear from Ben Lightburn, the Co-Founder & CEO of Filament Health.
Listed on the NEO Exchange, Filament Health have many irons in the psychedelic fire, spearheading clinical...
Investing in Psychedelics | Interview with Clara Burtenshaw & Sean McLintock, Neo Kuma Ventures
Clara Burtenshaw and Sean McLintock of Neo Kuma Ventures joined the GCI Content Hub in conversation about investing in psychedelics.
Could you give our readers an overview of your professional backgrounds, and what led you...
Psilocybin vs SSRIs for Depression
There is no doubt that psychedelic compounds hold the key to a slew of breakthroughs for many treatment-resistant conditions.
Ketamine-assisted therapy (albeit not strictly a psychedelic, but rather a substance that can create similar psychedelic...
Professionally Psychedelics Podcast – Zoe Helene, Cosmic Sister
The pod returns with a conversation with Zoe Helene, the Founder and Chief Visionary Officer of Cosmic Sister.
Zoe takes us on a psychedelic journey that kicked off in the 90s and delves into a...
Psychedelics in Europe
Watch insights from our Growing Landscape of Psychedelics in Europe discussion at the GCI Virtual Summit (June 2021) with Todd Shapiro, Red Light Holland; Anne Philippi, The New Health Club; Tim Cools, Psychedelic Experience.
To...
How Ketamine & Psychedelics Reveal Mechanisms Controlling Consciousness
Watch insights from our How Ketamine & Psychedelics Reveal Mechanisms Controlling Scope of Consciousness talk from the GCI Virtual Summit (June 2021) with Dr. Jeffrey Becker, Bexson Biomedical.
To meet, network and collaborate with global...
Raising Capital in Canadian Public Markets
Watch insights from the Raising Capital Through the Canadian Public Markets interview at the GCI Virtual Summit (June 2021) with Graham Dallas, Toronto Stock Exchange.
To meet, network and collaborate with global cannabis and psychedelic...
